doi: 10.3389/fnbeh.2026.1805953 Received 06 February 2026 Revised 13 March 2026 Accepted 13 March 2026 Published 13 April 2026 Volume 20 - 2026 Edited by Emmanuel Darcq, Institut National de la Sant et de la Recherche Mdicale (INSERM), France Reviewed by Zhe Zhao, Max Planck Florida Institute for Neuroscience (MPFI), United States Madhawi Aldhwayan, King Saud University, Saudi Arabia Updates Copyright 2026 OConnor
Together, they reduce hunger, quiet food cravings, and lower the mental noise around eating
When the body is adjusting to a new drug, it may respond in ways that include muscle cramps
Research has established correlations between low glycine levels and insulin resistance, with people who have obesity, prediabetes, and non-alcoholic fatty liver disease consistently showing lower circulating glycine concentrations compared to metabolically healthy individuals
Nausea, vomiting, diarrhea, constipation, and abdominal pain were the most common, mostly transient and mild to moderate